Bevacizumab--news from the fast lane?
Weller
Michael
M
Yung
W K Alfred
WK
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068258:Bevacizumab; D001932:Brain Neoplasms / Q000188:drug therapy*; D005910:Glioma / Q000188:drug therapy*; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068258:Bevacizumab
Clin Cancer Res. 2007 Feb 15;13(4):1253-9
17317837
J Clin Oncol. 2008 Feb 20;26(6):1012-3; author reply 1013
18281677
Neurology. 2008 Mar 4;70(10):779-87
18316689
Neuro Oncol. 2008 Oct;10(5):700-8
18697955